Search results

1. ESMO 2024 – combos could be the way forward for CDK2

   … Presentation ESMO 2024 ESMO 2024 ASCO 2023 ASCO 2024 Study Ph1 in solid tumours …

   
    

   Madeleine Armstrong
    
   - 09/15/2024 - 21:18

2. Replimune goes pivotal in uveal melanoma

   … R-, GM-CSF & anti-CTLA-4 Ph1 uveal melanoma data at ASCO 2024; ph2/3 begins Jan 2025 Note: …

   
    

   Madeleine Armstrong
    
   - 09/06/2024 - 15:47

3. Regeneron gets another bispecific blow

   … x CD28 Solid tumours (+ Libtayo) Ph1/2 data at ASCO 2024: 6% (3/51) ORR in MSS CRC; dose-expansion cohorts …

   
    

   Madeleine Armstrong
    
   - 08/23/2024 - 12:44

4. Tissue factor tempts Adcendo

   … DAR 3.8 Ph1/2 data in solid tumours presented at ASCO 2024 XNW28012 Evopoint Biosciences None …

   
    

   Madeleine Armstrong
    
   - 08/20/2024 - 14:15

5. Another vote of no-confidence in co-stimulated bispecifics

   … Ragistomig (ABL503) ABL Bio/ I-Mab Ph1 data at ASCO 2024 MCLA-145 Merus Ph1 Keytruda combo …

   
    

   Madeleine Armstrong
    
   - 08/07/2024 - 15:10

6. Boehringer takes on AbbVie in a novel checkpoint

   … Huadong Medicine PTPN2 inhibitor Preclinical data at ASCO 2024 Unnamed CD3 PTPN1/2 dual inhibitor …

   
    

   Madeleine Armstrong
    
   - 07/30/2024 - 15:58

7. Hookipa hopes for a head and neck fast track

   … 37% 53% CR rate 11% 18% Source: ASCO 2024. Data insights Trial …

   
    

   Madeleine Armstrong
    
   - 07/25/2024 - 13:39

8. Bristol overtakes Amgen in colorectal

   … 2022 based on Krystal-1; confirmatory Krystal-12 data at ASCO 2024 Ph3 Krystal-7, data due 2028 AA 2L Jun 2024 …

   
    

   Madeleine Armstrong
    
   - 06/25/2024 - 13:42

9. ASCO 2024 movers – Affimed wins, Caribou loses

   ASCO 2024 movers – Affimed wins, Caribou loses … tumbling 26%. Several other stocks moved yesterday too, but ASCO 2024’s most significant biotech beneficiary is …

   
    

   Jacob Plieth
    
   - 06/10/2024 - 16:07

10. ASCO 2024 – Yervoy makes the difference in front-line liver cancer

    ASCO 2024 – Yervoy makes the difference in front-line …

    
     

    Jacob Plieth
     
    - 04/14/2025 - 12:47